SOPHiA GENETICS grants equity awards to director Cox

SOPHiA GENETICS SA director Troy Cox received new equity awards tied to his board service.

Rhea-AI Filing Summary

SOPHiA GENETICS SA director Troy Cox received new equity awards tied to his board service. He was granted 19,724 restricted stock units, each representing one ordinary share valued at $5.46, bringing his direct holdings to 328,743 ordinary shares.

He also received options to purchase 28,818 ordinary shares at an exercise price of $5.46 per share, expiring on June 18, 2036, increasing his option holdings to 252,809. Both the RSUs and options were granted on June 18, 2026 and vest 100% at the date of the company’s next scheduled annual meeting of shareholders, contingent on his continued service.

Insider Trade Summary

Grant/Award: 48,542 shares

Grant/Award 2 txns

Insider Cox Troy

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Share Option (Right to Buy)	28,818	$5.46	$157K
Grant/Award	Ordinary Shares	19,724	$5.46	$108K

Holdings After Transaction: Share Option (Right to Buy) — 252,809 contracts (Direct); Ordinary Shares — 328,743 shares (Direct)

Footnotes (2)

1. F1. Represents a restricted stock unit ("RSU") grant. Each RSU represents a contingent right to receive one ordinary share of the Issuer, subject to Reporting Person's continued service with the Issuer. The RSUs were granted on June 18, 2026 and vest 100% as of the date of the Issuer's next scheduled annual meeting of shareholders.
2. F2. The share options were granted on June 18, 2026 and vest 100% as of the date of the Issuer's next scheduled annual meeting of shareholders, subject to the Reporting Person's continued service to the Issuer through the relevant vesting date.

Key Figures

RSU grant size: 19,724 shares RSU grant value per share: $5.46 per share Options granted: 28,818 shares +4 more

7 metrics

RSU grant size 19,724 shares Restricted stock units granted June 18, 2026

RSU grant value per share $5.46 per share Value used for RSU grant on June 18, 2026

Options granted 28,818 shares Share options granted June 18, 2026

Option exercise price $5.46 per share Exercise price for new share options

Option expiration June 18, 2036 Expiration date of new share options

Shares held after grant 328,743 shares Ordinary shares directly held after RSU grant

Options held after grant 252,809 options Total options following the new grant

Key Terms

restricted stock unit, RSU, share options, vest, +1 more

5 terms

restricted stock unit financial

"Represents a restricted stock unit ("RSU") grant. Each RSU represents a contingent right to receive one ordinary share"

A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.

RSU financial

"Represents a restricted stock unit ("RSU") grant. Each RSU represents a contingent right"

Restricted stock units (RSUs) are a form of company shares given to employees as part of their compensation, usually with certain restrictions or conditions, such as remaining with the company for a set period. When these restrictions lift, employees receive actual shares that they can sell or hold. For investors, RSUs can impact a company's stock supply and reflect the company's commitment to attracting and retaining talent.

share options financial

"The share options were granted on June 18, 2026 and vest 100% as of the date of the Issuer's next scheduled annual meeting"

Share options are contracts that give someone the right, but not the obligation, to buy a company’s stock at a predetermined price for a limited time—think of them like a coupon to purchase shares later at a set price. They matter to investors because when exercised they increase the number of outstanding shares (dilution), can change management incentives and company value, and represent a potential future claim on profits or equity.

vest financial

"vest 100% as of the date of the Issuer's next scheduled annual meeting of shareholders"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

contingent right financial

"Each RSU represents a contingent right to receive one ordinary share of the Issuer"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What equity awards did Troy Cox receive from SOPHiA GENETICS (SOPH)?

Troy Cox received 19,724 restricted stock units and options on 28,818 ordinary shares at $5.46 per share. Both awards were granted as director compensation and vest fully at the company’s next annual shareholder meeting, subject to his continued service on the board.

How many SOPHiA GENETICS (SOPH) shares does Troy Cox hold after this Form 4?

After the reported awards, Troy Cox directly holds 328,743 ordinary shares of SOPHiA GENETICS. He also has options covering 252,809 shares, including the new 28,818-share grant, providing additional potential future ownership if exercised under the specified terms.

When do Troy Cox’s new SOPHiA GENETICS RSUs and options vest?

Both the 19,724 restricted stock units and 28,818 share options vest 100% on the date of SOPHiA GENETICS’ next scheduled annual meeting of shareholders. Vesting is contingent on Troy Cox’s continued service to the company through that meeting date.

What is the exercise price and expiration for Troy Cox’s new SOPHiA GENETICS options?

The newly granted options allow Troy Cox to buy 28,818 ordinary shares at $5.46 per share. These options were granted June 18, 2026 and expire June 18, 2036, giving a ten-year window to exercise once vested at the next annual meeting.

Is Troy Cox buying or being granted SOPHiA GENETICS shares in this filing?

The filing reports compensation-related grants, not open-market purchases. Troy Cox received 19,724 restricted stock units and options for 28,818 shares as director awards, both vesting at the next annual shareholder meeting, rather than buying shares on the open market.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/22/2026 - 04:01 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Cox Troy

(Last) (First) (Middle)

C/O SOPHIA GENETICS INC.

401 PARK DRIVE, FLOOR 5

(Street)

BOSTON MASSACHUSETTS 02215

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
SOPHiA GENETICS SA [ SOPH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	06/18/2026		A		19,724(1)	A	$5.46	328,743	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Share Option (Right to Buy)	$5.46	06/18/2026		A		28,818		(2)	06/18/2036	Ordinary Shares	28,818	$5.46	252,809	D

Explanation of Responses:

1. Represents a restricted stock unit ("RSU") grant. Each RSU represents a contingent right to receive one ordinary share of the Issuer, subject to Reporting Person's continued service with the Issuer. The RSUs were granted on June 18, 2026 and vest 100% as of the date of the Issuer's next scheduled annual meeting of shareholders.

2. The share options were granted on June 18, 2026 and vest 100% as of the date of the Issuer's next scheduled annual meeting of shareholders, subject to the Reporting Person's continued service to the Issuer through the relevant vesting date.

Remarks:

	/s/ Elimara Brunetto as Attorney-in-Fact for Troy Cox	06/22/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)